Our platform technology is being developed to help simplify regeneration and allow cells to function naturally. With our launch product in development, SkinTE, we aim to be the first company to supply an autologous construct to regenerate a patient's skin due to a variety of injuries and conditions.
If successful in the burn market, we plan to explore entry into other markets, such as acute and chronic wounds, cosmetic/scar revisions, and hair regeneration.
In preclinical models, both cortical and cancellous bone were regenerated using the PolarityTE Platform, which has never been seen before.
The Holy Grail of tissue engineering - capillary bed formation and a vascular supply. PolarityTE aims to pull it off. Welcome to the Shift™.
It's time to up the game for soft tissue reconstruction. How about muscle regeneration? At PolarityTE, we aim to make contractile skeletal muscle constructs a reality.
Cartilage regeneration may be right around the corner with the PoalrityTE platform, which could allow us to battle arthritis with an appropriate weapon - autologous tissue.
Peripheral nerve regeneration has been lacking a key component for decades – cellular support. PolarityTE™ plans to change that.
Fat grafting has disrupted the field of plastic and reconstructive surgery in recent years. What if you could have an endless supply of fat for future application after a single harvest? On demand autologous fat for your patients? That’s where we’re headed.